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PVSS10.
National Outcomes and Charges for Claudication and
Limbthreat: Angioplasty Versus Bypass Graft
Teviah Sachs, Frank Pomposelli, Mark Wyers, Allen Ham-
dan, Marc L. Schermerhorn. Beth Israel Deaconess Medi-
cal Center, Boston, MA
Objectives: Assess Outcomes & Costs in Patients with
Lower Extremity Vascular Disease Undergoing Intervention.
Methods: We used the NIS database (1998-07), se-
lecting those with atherosclerosis & intervention for clau-
dication (CL) [ICD-9: 440.21] or limbthreat (LT)
[440.22-24] with angioplasty / stent (PTA) [39.50,
39.90], aorto-femoral bypass (AFB) [39.25], & peripheral
bypass (BPG) [39.29]. We evaluated demographics, co-
morbidities, charges & adjusted mortality & major ampu-
tation.
Results: There were 563, 142 patients: PTA: 218, 656
(38%), BPG: 280, 022 (50%), AFB: 36, 307 (6%). PTA
patients were older than BPG (71 v 70y), more often
female (46 v 42%), had similar but lower mortality than
BPG for CL (.2 v .4%) and LT (2.1 v 2.5%). PTA had higher
major amputation for LT (7% v 4%) [all p 0.01]. Median
LOSwas lowest for PTA (CL:1d, LT:3d), followed by BPG
(CL:3d, LT:6d) and AFB (CL:5d, LT:7d) [all p  0.01].
Total procedures for CL rose 58% (24, 488 - 38, 785),
while charges rose 228% ($0.46 - $1.5 billion). Procedures
for LT rose 5% (34, 402 - 36, 147) while charges rose 112%
($1.1 to $2.3 billion) [Figure]. For CL and LT, PTA has
surpassed BPG & AFB combined.
Conclusions: PTA has altered the treatment paradigm
for lower limb ischemia with increased procedures &
charges. It is unclear if this represents an increase in patients
or number of treatments per patient. Although mortality is
lower with PTA, limb loss appears higher, necessitating
longitudinal studies to determine the appropriateness of
PTA for these patients. Themortality benefit with PTAmay
be ultimately lost if multiple interventions are performed
on the same patients.
Author Disclosures: A. Hamdan: Nothing to disclose; F.
Pomposelli: Nothing to disclose; T. Sachs: Nothing todisclose; M. L. Schermerhorn: Boston Scientific, Consult-
ing fees or other remuneration (payment); M. Wyers:
Nothing to disclose.
PVSS11.
Management of Dialysis-Dependent Patients With
Critical Limb Ischemia
Jonathan Kittredge3, Purandath Lall2, Linda M. Harris3,
Maciej L. Dryjski3, Hasan H. Dosluoglu1. 1SUNY at Buf-
falo, VAWestern NYHealthcare System, Buffalo, NY; 2VA
Western NY Healthcare System, Buffalo, NY; 3SUNY at
Buffalo, Buffalo, NY
Objectives: The goal of our study was to assess the
current management strategies in dialysis-dependent pa-
tients with critical limb ischemia (CLI), and to identify
parameters associated with limb loss in this patient popula-
tion.
Methods: Dialysis-dependent patients who presented
with CLI (Rutherford 4-6) between 06/2001-06/2009
were retrospectively analyzed.
Results: There were 94 patients (82% males, 119
limbs, mean age 67  10). Co-morbidities included CAD
(87%), hypertension (86%), DM (78%), non-ambulatory
status (26%). Indications were rest pain (18%), non-healing
ulcer (23%), gangrene (53%), and advanced foot sepsis
(7%). Primary amputation (PA) was performed in 20%; 26%
underwent open bypass, 54% had endovascular (EV) inter-
ventions. More EV-treated patients had gangrene than
open group (63% vs 39%, p  0.047). The most distal
intervention was infrapopliteal in 47% of patients (open,
51%; endovascular, 62%, p 0.259). Two-year survival was
worse in PA group (21 8%, vs 51 9% in open, 41 7%
in EV, p  0.088). Limb salvage (LS) was similar in open
and EV groups (2-year LS 60  9.7% vs 58  8%, p 
0.690). Amputation-free survival (AFS) was also similar
(2-year AFS 38 9% in open vs 28 6% in EV, p 0.304).
Multivariate analysis showed only non-ambulatory status
(OR: 3.0, 95% CI, 1.4-6.8, p  0.007) and gangrene
(OR:2.7, 1.1-6.5, p  0.027) being independently associ-
ated with limb loss after limb salvage attempt. The LS rate
was 0% at 6 months in non-ambulatory patients with gan-
grene (n  15), whereas it was 70  8% in ambulatory
patients with gangrene (n  37). Only 6 of the 15 non-
ambulatory patients with gangrene who had LS attempt did
not have an amputation; all died within 3 months with
non-healed wounds.
Conclusions:EV interventions play a significant role in
the current management of dialysis-dependent patients
with CLI, with similar results to open reconstructions.
Non-ambulatory dialysis patients with gangrene carry a
dismal prognosis and primary amputation should be con-
sidered as the initial modality.
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Socioeconomic and Hospital-Related Predictors of
Amputation for Critical Limb Ischemia
Antonia J. Henry1, Nathanael Hevelone2, Neal R.
Barshes1, Michael Belkin1, Louis L. Nguyen1. 1Brigham
and Women’s Hospital Division of Vascular and Endo-
vascular Surgery, Boston, MA; 2Brigham and Women’s
Hospital Center for Surgery and Public Health, Boston,
MA
Objectives: Disparities in limb salvage procedures may
be driven by socioeconomic status (SES) and access to high
volume hospitals. We sought to identify SES factors asso-
ciated with major amputation in the setting of critical limb
ischemia (CLI).
Methods: The 2007 Nationwide Inpatient Sample
was queried for discharges containing lower extremity
revascularization (LER), major amputation, and chronic
CLI (N  152, 736). The Elixhauser method was used
to adjust for comorbidities. Significant predictors in
bivariate logistic regression were entered into a multivar-
iate logistic regression for the dependent variable of
amputation vs LER.
Results: Overall, 18.1% of CLI patients underwent
amputation. Significant differences were seen between both
groups in bivariate and multivariate analysis of SES factors,
including race, income, and insurance status (Table 1).
Lower income patients weremore likely to be treated at low
LER volume institutions (OR 1.44, p 0.017). Patients at
higher LER volume centers (OR 2.11, p  0.001), admit-
ted electively (OR 1.96, p  0.001) and evaluated with
diagnostic imaging (OR 4.30, p 0.001) were more likely
to receive LER.
Conclusions: After controlling for comorbidities, mi-
nority patients, those with lower SES, and patients with
Medicaid were more likely receive amputation for CLI in
low volume hospitals. Addressing SES and hospital factors
may reduce amputation rates for CLI.





Male gender 1.22 (p0.001) 1.13, 1.32
Black vs White race 2.33 (p0.001) 2.02, 2.69
Hispanic vs White race 1.37 (p0.001) 1.16, 1.62
Median income
\$39, 000 1.25 (p0.005) 1.08, 1.45
\$39, 000-47, 999 1.11 (p0.159) 0.96, 1.28
\$48, 000-62, 999 1.03 (p0.682) 0.88, 1.21
\$63, 000 ref
Private payer vs Medicare 0.83 (p0.002) 0.74, 0.94
Medicaid vs Medicare 1.24 (p0.015) 1.04, 1.48
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Genetic Influences on Peripheral Arterial Disease in a
Twin Population
Carl Wahlgren1, Patrik K. Magnusson2. 1Department of
Vascular Surgery, Karolinska University Hospital & Karo-
linska Institute, Stockholm, Sweden; 2Department ofMed-
ical Epidemiology and Biostatistics, Karolinska Institute,
Stockholm, Sweden
Objectives: The understanding of genetics in periph-
eral arterial disease (PAD) is still limited. The aim of this
study was to analyze the contribution of genetic and envi-
ronmental factors to the development of PAD in a large
population-based sample of twins.
Methods: The Swedish Twin Registry was cross-
linked with the Inpatient Registry, providing national
coverage of discharge diagnoses. All twins with athero-
sclerosis of extremity arteries, including claudication and
critical limb ischemia, were identified. Concordance
rates and tetrachoric correlations were calculated for
monozygotic (MZ) and dizygotic (DZ) twins. Structural
equation modeling techniques, Mx-analyses, were used
to estimate the contribution of genetic effects as well as
shared and non-shared environmental factors to devel-
opment of PAD.
Results: In the registry, 76977 twins were born
between 1886 and 1957. There were 964 twins with
PAD including 20 MZ and 22 DZ concordant pairs as
well as 216 MZ and 664 DZ discordant pairs. The
probandwise concordance rates for MZ and DZ pairs
were 15.6% and 6.2%, respectively. The tetrachoric cor-
relations were 0.52 in MZ pairs and 0.30 in DZ pairs.
The odds ratio was 16.4 (95% CI: 9.8-27.4) for MZ
twins and 5.6 (95% CI: 3.6-8.7) for DZ twins. In the
structural equation models, genetic effects accounted for
44 % (95% CI: 0.16-0.61), shared environmental effects
for 8.0 % (95% CI: 0-0.28), and non-shared environmen-
tal effects for 48% (95% CI: 0.39-0.59) of the phenotypic
variance among twins.
Conclusions: Heritability is an important component
along with unique environmental factors for development
of PAD. Concordances and correlations were higher inMZ
compared with DZ twins, indicating genetic influences in
PAD. The twin of an MZ twin with PAD had a risk of PAD
that was 16 times that of the MZ twin of a person without
PAD. A better understanding of the genetics in PAD could
identify individuals at increased risk who may benefit from
targeted therapies.
